New mRNA Vaccine Helps Prevent Deadliest Skin Cancer from Returning
A personalized mRNA cancer vaccine, intismeran autogene, combined with the immunotherapy drug Keytruda has demonstrated positive phase 3 clinical trial results in preventing melanoma recurrence. Developed by Moderna and Merck, … Read More